Dr. Zaenker founded Praevomed GmbH in Germany, which works in the field of cancer prevention, food supplements and nutritional oncology and attempts to short-cut the translation of laboratory findings into the health-care market. Praevomed is the patent holder of a new class of anti-cancer agents which have already been finished successfully.